Association of osteopontin and tumor necrosis factor-α levels with insulin resistance in obese patients with obstructive sleep apnea syndrome

Journal of Endocrinological Investigation

Volumn 34, Issue 7, 2011, Pages 528-533

  Sarac, F ^a   Basoglu, O K ^a   Gunduz, C ^a   Bayrak, H ^a   Biray Avci, C ^a   Akcicek, F ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Insulin resistance; Obesity; Obstructive sleep apnea syndrome; Osteopontin; TNF

Indexed keywords

FIBRINOGEN; INSULIN; OSTEOPONTIN; THYROTROPIN; THYROXINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APNEA HYPOPNEA INDEX; ARTERIAL GAS; ARTICLE; CONTROLLED STUDY; EPWORTH SLEEPINESS SCALE; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEUKOCYTE COUNT; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYSOMNOGRAPHY; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME; SPIROMETRY; THYROXINE BLOOD LEVEL;

ADULT; AGED; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; OSTEOPONTIN; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054110654     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7287     Document Type: Article

References (38)

1. Inancli HM, Enoz M. Obstructive sleep apnea syndrome and upper airway inflammation. Recent Pat Inflamm Allergy Drug Discov 2010, 4: 54-7.
2. Gozal D, Kheirandish-Gozal L. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med 2008, 177: 369-75. (Pubitemid 351317579)
3. Otake K, Sasanabe R, Hasegawa R, et al. Glucose intolerance in Japanese patients with obstructive sleep apnea. Intern Med 2009, 48: 1863-8.
4. Harsch IA, Wallaschofski H, Koebnick C, et al. Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance. Respiration 2004, 71: 580-6. (Pubitemid 40091430)
5. Harsch IA, Koebnick C, Wallaschofski H, et al. Resistin levels in patients with obstructive sleep apnea syndrome-the link to subclinical inflammation? Med Sci Monit 2004, 10: CR510-5. (Pubitemid 39278559)
6. Makino S, Handa H, Suzukawa K, et al. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) 2006, 64:12-9.
7. Liu H, Liu J, Xiong S, Shen G, Zhang Z, Xu Y. The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome. J Tongji Med Univ 2000, 20: 200-2. (Pubitemid 33210383)
8. Ciftci TU, Kokturk O, Bukan N, Bilgihan A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 2004, 28: 87-91. (Pubitemid 39302489)
9. Vgontzas AN, Papanicolaou DA, Bixler EO. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997, 82: 1313-6. (Pubitemid 27200394)
10. O'Regan AW, Nau GJ, Chupp GL, Berman JS. Osteopontin (Eta-1) in cell-medicated immunity: teaching an old dog new tricks. Immunol Today 2000, 21: 475-8.
11. Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB J 1993, 7: 1475-82. (Pubitemid 24003267)
12. Trayhurn P, Wang B, Wood IS. Hypoxia and the endocrine and signalling role of white adipose tissue. Arch Physiol Biochem 2008, 114: 267-76.
13. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14: 540-5.
14. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring for sleep stages of human subjects. Los Angeles: Brain Information Service/Brain Research Institute, University of California, 1968.
15. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999, 22: 667-89.
16. Mohn A, Marcovecchio M, Chiarelli F. Validity of HOMA-IR as index of insulin resistance in obesity. J Pediatr 2006, 148: 565-6.
17. Jun J, Polotsky VY. Metabolic consequences of sleep-disordered breathing. ILAR J 2009, 50: 289-306.
18. Vgontzas AN, Papanicolaou DA, Bixler EO. Sleep apnea and day-time sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000, 85: 1151-8. (Pubitemid 32269364)
19. Naldini A, Leali D, Pucci A, et al. Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes. J Immunol 2006, 177: 4267-70. (Pubitemid 44469753)
20. Yu XQ, Fan JM, Nikolic-Paterson DJ, et al. IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat. Am J Pathol 1999, 154: 833-41. (Pubitemid 29122602)
21. Noda M, Nagao M, Hanyu R, Miyai K, Ezura Y. Bone fracture and the healing mechanisms. Molecular bases of fracture healing. Clin Calcium 2009, 19: 634-40.
22. Chaplet M, Waltregny D, Detry C, Fisher LW, Castronovo V, Bellahcène A. Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness. Int J Cancer 2006, 118: 850-6. (Pubitemid 43157660)
23. Xue S, Shen D, Gao H, Wang Y. Simple obesity is associated with reduced breast arterial calcification and increased plasma osteopontin level. Arch Med Res 2008, 39: 607-9.
24. Nomiyama T, Perez-Tilve D, Ogawa D, et al. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 2007, 117: 2877-88. (Pubitemid 47529618)
25. Bertola A, Deveaux V, Bonnafous S, et al. Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver Steatosis in morbid obesity. Diabetes 2009, 58: 125-33.
26. Gómez-Ambrosi J, Catalán V, Ramírez B, et al. Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab 2007, 92: 3719-27. (Pubitemid 47435361)
27. Schaller G, Aso Y, Schernthaner GH, et al. Increase of osteopontin plasma concentrations after bariatric surgery independent from inflammation and insulin resistance. Obes Surg 2009, 19: 351-6.
28. Takabatake N, Nakamura H, Abe S, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 161: 1179-84. (Pubitemid 30243827)
29. Dyugovskaya L, Lavie P, Lavie L Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 2003, 168: 242-9. (Pubitemid 36920981)
30. Dyugovskaya L, Lavie P, Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Acad Sci 2005, 1051: 340-50. (Pubitemid 41362764)
31. Dyugovskaya L, Polyakov A, Lavie P, Lavie L. Delayed neutrophil apoptosis in patients with sleep apnea. Am J Respir Crit Care Med 2008, 177: 544-54. (Pubitemid 351442194)
32. Kanbay A, Kokturk O, Ciftci TU, Tavil Y, Bukan N. Comparison of serum adiponectin and tumor necrosis factor-alpha levels between patients with and without obstructive sleep apnea syndrome. Respiration 2008, 76: 324-30.
33. Li Y, Chongsuvivatwong V, Geater A, Liu A. Are biomarker levels a good follow-up tool for evaluating obstructive sleep apnea syndrome treatments? Respiration 2008, 76: 317-23.
34. Alberti A, Sarchielli P, Gallinella E, et al. Plasma cytokine levels in patients with obstructive sleep apnea syndrome: A preliminary study. J Sleep Res 2003, 12: 305-11. (Pubitemid 38010437)
35. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. Clin Endocrinol Metab 2000, 85: 1151-8. (Pubitemid 32269364)
36. Yao SM, Zhang XL. Association between residual sleepiness and central sleep apnea events in patients with obstructive sleep apnea syndrome. Zhonghua Jie He He Hu Xi Za Zhi 2008, 31: 664-9.
37. Makino S, Fujiwara M, Suzukawa K, et al. Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome. Horm Metab Res 2009, 41: 221-6.
38. Stoohs RA, Facchini F, Guilleminault C. Insulin resistance and sleep disordered breathing in health humans. Am J Respir Crit Care Med 1996, 154: 170-4. (Pubitemid 26255785)